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A
confluence of forces is challenging traditional approaches to issues of quality in substance abuse care. The availability of 
effective, research-based interventions, the Federal emphasis on performance measurement and outcomes, and national
initiatives to improve quality and data infrastructure are driving a transition from a static, compliance-oriented approach to a
more dynamic performance improvement model. This new way of achieving and documenting quality will produce better out-
comes for consumers and greater confidence in the value of substance abuse services, but first it will require new behaviors from
all parties involved in the delivery of substance abuse prevention and treatment services. This article describes some of the shifts
already under way and offers advice on how organizations can get ready for the coming changes.
Quality and Performance Improvement: What’s a Program to Do?
onsider the following situations:
While cleaning your 16-year-old daughter’s room, you come across
a stash of pills. You’ve been aware of several changes in her behavior and
attitude over the past 6 months. Her grades are down, and she has become surly
and secretive; but you’ve been telling yourself not to worry, as surely all teenagers
go through these phases. Now, standing in her room, you have the sinking feeling
that your child is in trouble. After a heated confrontation with your daughter, you
decide to call your managed care plan, which gives you the names of several pro-
grams and therapists available under your coverage. But how do you choose among
them? You feel you may be confronting one of the most significant moments in
your child’s young life, but how do you decide whom to call, with your daughter’s
future possibly hanging on the decision?
You’re the assistant secretary for human services in the Governor’s office. You’ve
been a thoughtful advocate for the needs of people with behavioral health disor-
ders. This year’s budget is going to require cuts in the substance abuse service deliv-
ery system. You dislike the “percentage cut across the board” approach to system
management. You’ve visited programs and have a feel for which programs appear
to work better, but you realize that your subjective opinion based on a limited
number of site visits will hardly carry the day if programs are cut selectively.
How can you manage the downsizing process so that it has the least possible impact
on the overall effectiveness of the system and the care delivered to people in need?
A lack of quality information isn’t the only challenge facing parents or system
managers. Often, the available information is contradictory or lacks sufficient rigor 
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to be useful for making decisions. In an article in The
New York Times Magazine, David Sheff described his
experience seeking help for his methamphetamine-
addicted 19-year-old son, Nick (Sheff, 2005). As Sheff
sought to determine the best course of action, he was
often given conflicting advice. For example, one pro-
gram advised Sheff to have Nick arrested, while another
warned him not to do anything that might alienate his
son. What advice has merit, Sheff wondered, and how
can I distinguish? Sheff concluded that the substance
abuse service system “must be the most chaotic, flailing
field of health care in America.”
The Institute of Medicine (IOM), a nonprofit sci-
entific organization chartered by Congress to inform
and advise policymakers, addressed the need to improve
the quality of substance abuse treatment nationwide in
a milestone report entitled Bridging the Gap Between
Practice and Research: Forging Partnerships With Community-
Based Drug and Alcohol Treatment (Lamb, Greenlick,
and McCarty, 1998). The report recommended that
system and program managers promote the use of
evidence-based practices (EBPs) in community treat-
ment settings through funding and other incentives. A
subsequent publication, Improving the Quality of Health
Care for Mental and Substance-Use Conditions(Institute
of Medicine, 2005), offers a broad vision of system trans-
formation for the 21st century. It promotes a patient-
centered system that is an equal partner in the coun-
try’s health care system, one that is grounded in the
application of EBPs and committed to performance
improvement based on objective, transparent meas-
urement. Although the IOM recognizes the formida-
ble obstacles to realizing this vision, it also defines the
components of system transformation and challenges
the field to mobilize the resources to move forward
on an agenda for quality (see “Ten Rules To Guide
the Redesign of Health Care”). 
AGENDA FOR IMPROVEMENT 
Implementing a quality and performance improvement
(QPI) agenda at a system or individual provider level
can be compared to building a three-legged stool. The
three supports upon which the system will rest are the
implementation of improvements in the delivery of care,
including the adoption of empirically tested, effective
clinical and administrative practices (the content); the
measurement of results (the data); and a QPI method
to establish and sustain the advances in quality (the
process).
Some people would argue that a fourth leg may be
the availability of human and financial resources com-
mensurate with the breadth of the undertaking. A review
of needs and available resources is required prior to build-
ing the stool and, hence, is implicit in this discussion.
Leg One: Evidence-Based Practices (the Content)
The substance abuse services community has not always
recognized the contribution of well-designed research
studies to improvements in the quality of substance
abuse services. Although the world-class studies of the
neurochemistry of addiction have fascinated the field
and the general public, the products from the more mun-
dane studies of effective treatment interventions have
not been as widely distributed or as warmly received.
Perhaps a relative shortage of user-friendly tools or the
complexities of implementing an EBP with fidelity have
diminished enthusiasm.
Programs have at their disposal several sources that
offer information and, in some cases, technical assis-
tance in selecting and implementing EBPs. Among these
sources are the Substance Abuse and Mental Health
Services Administration’s National Registry of Evidence-
Based Programs and Practices, the National Quality
Forum, and NIDA’s Clinical Trials Network. 
National Registry of Evidence-Based Programs and
Practices
The U.S. Substance Abuse and Mental Health Services
Administration (SAMHSA) recently expanded its National
Registry of Evidence-Based Programs and Practices
(NREPP) to include treatment as well as prevention
interventions. Treatment providers can consult the
NREPP Web site for guidance in selecting the EBP that
is best suited to their patients’ needs and program struc-
ture. The NREPP divides the EBPs into three categories:
promising practices, effective practices, and model pro-
grams. In addition to a rigorous review of the research
on each model program and practice, the NREPP now
assesses its readiness for dissemination and adoption
(e.g., are user-friendly materials and technical assistance
available to providers or practitioners?). The NREPP
will enable a program’s leadership to make thoughtful
decisions about the suitability of a particular EBP and
to consider what resources may be available to assist staff
in implementing the practice. SAMHSA plans to have
a redesigned NREPP Web site operational by spring
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National Quality Forum
The National Quality Forum (NQF) is another promi-
nent group working to identify EBPs for use in 
community-based health and substance abuse treatment
settings. The NQF, established in 1999 pursuant to
Federal legislation, is a standards-setting organization
for health care whose 300 members represent all aspects
of the industry, including consumers, purchasers, providers,
researchers, and quality improvement organizations. In
its initial report on substance abuse, Evidence-Based
Treatment Practices for Substance Use Disorders (Power,
Nishimi, and Kizer, 2005), the NQF recommended
seven categories of practice for consensus-building
and quality measurement efforts: (1) screening, (2) ini-
tial brief intervention, (3) prescription for services, 
(4) psychosocial interventions, (5) pharmacotherapy,
(6) patient engagement and retention, and (7) recovery
management. A draft consensus report on these prac-
tices should be available by spring 2007. To view the
NQF’s workshop recommendations, visit www.
qualityforum.org/projects/ongoing/sud.asp. 
Clinical Trials Network
NIDA’s Clinical Trials Network (CTN) brings together
researchers and practitioners to study the effective-
ness of well-researched interventions when they are
implemented in community-based treatment settings.
NIDA’s support of the CTN recognizes that practices
shown to be efficacious under strictly controlled research
conditions need to be tested in the real-world settings
of community-based treatment programs, whose patients
are more diverse and whose capacity to implement an
EBP may vary considerably. The CTN’s “effectiveness
research” provides an important laboratory for researchers
and clinicians to study and evaluate the most promis-
ing of the interventions before wider distribution and
dissemination efforts are undertaken. Nationwide, the
CTN includes more than 130 community treatment
programs and 17 research centers (www.nida.nih.
gov/CTN).
Even in the CTN, however, EBP implementation
remains somewhat more controlled and draws on more
resources than community-based treatment programs
typically enjoy. If the CTN’s research studies find a prac-
tice or intervention to be highly effective, the task of trans-
lating the intervention into clinically useful tools and dis-
seminating them to the field remains. The Blending
Initiative of NIDA and SAMHSA aims to meet this need.
It brings together CTN researchers and the technology
transfer experts of SAMHSA’s Addiction Technology
Transfer Centers (ATTCs) to create the clinician-friendly
products needed to move a practice out of the research
arena and into wider use in treatment settings. The
Blending teams have completed products for three EBPs
to date: training of addiction professionals in buprenor-
phine treatment, use of buprenorphine for short-term
opiate withdrawal, and use of the Addiction Severity
Index in treatment planning. Teams are currently work-
ing on packages to support two other EBPs: clinical
supervisors’ use of motivational interviewing and pro-
motion of awareness of motivational incentives. For
Adapted from Institute of Medicine, 2005.
Ten Rules To Guide the Redesign of Health Care
1. Care is based on continuous healing relationships. Patients receive
care whenever they need it and in many forms. The health care system is
responsive 24 hours a day, every day; it is accessible over the Internet, by
telephone, and by other means in addition to face-to-face visits.
2. Care is customized to patient needs and values. The system of care
meets the most common types of needs and is able to respond to indi-
vidual patient choices and preferences.
3. Patients receive full information about their condition and care
options. Clinicians and patients communicate effectively and share infor-
mation.
4. Patients exercise the degree of control they choose over the health care
decisions that affect them.
5. Clinical decisions are evidence-based. Patients receive care based on
the best available scientific knowledge. Care does not vary illogically from
clinician to clinician or place to place.
6. Safety is built into the care system. The system includes mechanisms
to prevent and mitigate errors and keep patients safe from iatrogenic
injury.
7. Consumers have open access to information on health care organiza-
tions’ practices and performance. Patients and their families can obtain
adequate information to make informed decisions when selecting a
health plan, hospital, or clinical practice. The information includes data
on organizations’ safety records, evidence-based practices, and patient
satisfaction scores.
8. The health care system anticipates patient needs, rather than simply
reacting to events.
9. Waste decreases continuously. The health care system does not waste
resources or patient time.
10. Clinicians and institutions actively collaborate and communicate to
ensure an appropriate exchange of information and coordination of care.40 • SCIENCE & PRACTICE PERSPECTIVES—APRIL 2007
more information on Blending Initiative products, visit
www.nida.nih.gov/blending.
The ATTCs have independently developed a wealth
of resources to assist programs in selecting and imple-
menting an EBP. The ATTC Web site (www.nattc.
org/index.html) provides access to products from all 17
ATTC regional centers, covering topics as diverse as clin-
ical interventions (e.g., motivational interviewing, addic-
tion medications) and management strategies (e.g., opti-
mizing use of Web time, managing change).
Leg Two: Performance Measurement (the Data)
Whether programs are implementing an EBP or tweak-
ing a current practice to improve the quality of care, they
need valid and reliable data to measure their perform-
ance and track their progress. Purchasers need solid,
objective information to ensure that their investment
yields sufficient value; regulators need it for accounta-
bility purposes; and consumers cannot make informed
decisions about their choice of providers without it. 
Performance measurement means developing, spec-
ifying, and testing measures to compare providers and
service systems in core performance areas. It is “the selec-
tion and use of quantitative measures of program capac-
ities, processes and outcomes to inform the public or a
designated public agency about critical aspects of a pro-
gram, including its effects on the public” (Perrin, Durch,
and Skillman, 1999). Among sources programs may
look to for help in choosing and implementing appro-
priate performance measures and standards are the
Washington Circle and SAMHSA’s National Outcome
Measures.
The Washington Circle
In March 1998, the Center for Substance Abuse Treatment
convened a multidisciplinary group of providers, researchers,
managed care representatives, and public policy repre-
sentatives to develop performance measures for sub-
stance abuse services. The Washington Circle (WC), as
the group came to be known, established two broad goals
(McCorry et al., 2000): 
• Develop and pilot-test a core set of performance meas-
ures for use in the public and private sectors; and
• Collaborate with a broad range of stakeholders to ensure
widespread adoption of substance abuse performance
measures by health plans, private employers, public
payers, and accrediting organizations.
The WC has completed the specification and test-
ing process for three measures: identification, initiation,
and engagement in care in managed care settings. These
can be computed from existing administrative encounter
and billing data (Garnick et al., 2002); readers can obtain
detailed programming specifications at www.
washingtoncircle.org. The WC measures have been
adapted by several national and state organizations to
evaluate their members’ performance in delivering the
early phases of treatment. For example, the National
Committee on Quality Assurance (NCQA) has incor-
porated the WC measures into its standardized per-
formance measurement system, the Health Plan Employer
Data and Information Set (HEDIS). The perform-
ance of NCQA-accredited health plans on these meas-
ures is published and available, at a cost, to purchasers
of care. Consumers can request information on specific
HEDIS scores by contacting their health plan repre-
sentative. This transparency is a boon for consumers
dealing with alcohol or drug problems. The publication
of the HEDIS results also motivates health plans to
improve their performance to remain competitive with
other health plans.
The WC is working with a dozen states to adapt the
three specified measures to public sector systems, which,
unlike managed care plans, have no “enrolled popula-
tion” to determine their success in identifying and engag-
ing individuals in need of treatment. Initial testing
and modification of the WC specifications to fit the data
capacities of block-grant-funded state systems have
yielded promising results (Garnick, Horgan, and Chalk,
2006). Participating states continue to shape the WC
measures to account for the multiple pathways through
which a person in need may be identified and initiated
into block-grant-supported care. 
The WC currently is working on three new meas-
ures to expand its core measurement set in the preven-
tion, treatment, and maintenance of treatment effects
domains. The measures are: screening for alcohol and
other drugs, medication-assisted treatment, and recov-
ery management services. Specification and pilot-
testing information on these measures will also be avail-
able on the WC Web site in spring 2007.
Another source of information on a provider’s or
plan’s performance in delivering substance abuse serv-
ices—besides administrative databases—is the consumer
population. The WC is working with the Forum on
Performance Measures in Behavioral Healthcare to
develop and test a consumer survey that elicits patients’
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The survey consists of two modules: one is specific to
substance abuse treatment and recovery, and the other
is equally effective in surveying consumers of substance
abuse treatment services and consumers of other men-
tal health services. Testing of both modules is nearly
completed, and the final survey will be posted on the
WC Web site in spring 2007.
National Outcome Measures
The IOM report on mental health and substance abuse
recognized that individuals with substance use disorders
and other mental illnesses face similar challenges—for
example, the neurobiological embedding and chronic-
ity of their problems, stigma, and public skepticism about
the effectiveness of treatments (Institute of Medicine,
2005). In an effort to bring some consistency to meas-
uring outcomes for consumers with these conditions,
SAMHSA, in collaboration with the state directors of
mental health and addictive disorders, has identified a
common set of measures for both fields. The National
Outcome Measures, although they may be specified some-
what differently for mental health and substance abuse
services, capture treatment outcomes that meaningfully
reflect recovery in both conditions (see “SAMHSA National
Outcome Measures for Substance Abuse Treatment and
Prevention”). A majority of states are already reporting
on some of these measures; SAMHSA anticipates that
all states will have comprehensive reports by October
2007, resulting in the first “national picture” of outcomes.
That picture, in turn, should provide the basis for a con-
centrated effort to improve performance in settings whose
profiles indicate poorer performance. For an in-depth
look at the National Outcome Measures and SAMHSA’s
performance management strategy, visit www.
nationaloutcomemeasures.samhsa.gov/outcome/index.asp.
Leg Three: Quality and Performance Improvement
Methods (the Process)
Why do science-based practices seem to work their way
into everyday practice so slowly? Why do some well-
researched practices never become routine?
The lag time between discovery and widespread appli-
cation of an innovation is not a new issue: The British
Admiralty did not mandate that Navy diets include cit-
rus fruits until nearly 200 years after the initial findings
that they prevent scurvy. Recently, however, the emerg-
ing field of implementation science has begun to make
progress in understanding the factors that facilitate or
inhibit adoption of innovations. An excellent mono-
graph by Fixsen and colleagues (2005) describes the
implementation of innovations as a multilevel process
involving strategies (e.g., the availability of coaching to
the users of the innovation), organizational dynamics
(e.g., leadership endorsement and organizational readi-
ness to change), and external influences (e.g., state agency
regulations and reimbursement practices). Together,
these three forces interact to promote or doom the inno-
vation. Fixsen and colleagues’ review of the literature
suggests that even the most effective, well-researched
practices will fail without an adequate implementa-
tion strategy. 
Achieving the promise of improved outcomes through
the implementation of innovative practices, including
EBPs, and the transparent measurement of performance
will require partnerships among government, purchasers,
and providers. The Network for the Improvement of
Addiction Treatment, a collaborative project between
SAMHSA’s Center for Substance Abuse Treatment and
The Robert Wood Johnson Foundation, has been a leader
in fostering these partnerships.
The Network for the Improvement of Addiction
Treatment 
For busy chief executive officers or clinicians, the thought
of changing business or clinical practices can seem daunt-
ing. They may worry that the change exercise will add
burdens—more paperwork, more meetings, more goal-
setting—and produce uncertain or disappointing results.
Past experience with state quality improvement regula-
tions and accreditation requirements may have rein-
forced the notion that QPI is just a writing exercise,
extraneous to the real work of the organization.
The Network for the Improvement of Addiction
Treatment (NIATx), which is based at the University of
Wisconsin, is collaborating with providers and state
agencies across the United States to overcome these
potential pitfalls. The NIATx has identified a set of crit-
ical ingredients for successful organizational change and
is assisting providers and state agencies in identifying
practical, efficient ways to improve patient outcomes
and provider bottom lines. Specifically, the NIATx and
its collaborating programs are focusing on practices that
can reduce treatment seekers’ waiting times and no-
shows and increase admissions and early retention rates.
Dr. David Gustafson and colleagues at the University
of Wisconsin have developed a rapid-cycle quality improve-
ment process to implement the changes in the access
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Reduced morbidity
Employment/education





or return to/retention in school
Decreased criminal justice
involvement
Increased stability in housing
Increased retention in treatment
Change in frequency of use at
date of last service compared to
date of first service
Change in percentage of clients
employed or in school at date of
last service compared to first
service
Change in number of arrests in
past 30 days from date of first
service to date of last service 
Change in percentage of clients
in stable housing situation at
date of last service compared to
date of first service 
Changes in length of stay from
date of first service to date of
last service
Unduplicated count of persons
served
Changes in 30-day substance
use prevalence, age of first
use, and perception of the
risks of drug use
Change in alcohol- and drug-
related termination, suspen-
sion, and expulsion rates;
change in attendance, enroll-
ment, and employment rates
Change in number of alcohol-
related car crashes and
injuries; change in prevalence
of alcohol- and drug-related
crime
Not applicable
Total number of evidence-
based programs and strate-
gies; change in percentage of
clients seeing, reading,




SAMHSA NATIONAL OUTCOME MEASURES FOR SUBSTANCE ABUSE TREATMENT AND PREVENTION 
This table has been modified from the original, which is available at www.nationaloutcomemeasures.samhsa.gov/outcome/index.asp.
ments implemented by treatment agencies, as well as
introductory materials that interested agencies can use
to get started.
GETTING STARTED
What should a busy chief executive officer, clinical direc-
tor, counselor, or state agency manager do to formulate
and carry out an agenda for quality? There are a num-
ber of steps a manager can take to move the quality agenda
to his or her organization’s front burner.
Provider Clinical and Executive Leadership
Begin To Quantify and Measure Performance
Many people believe performance measurement is a
complicated business requiring specialized skills and
“Plan-Do-Study-Act” process does not bog down in end-
less reports and meetings; rather, it emphasizes a plan-
ning, implementation, and evaluation cycle that is sim-
ple, fast, and inclusive. The method features ongoing
support for the change process through learning 
collaboratives facilitated by expert coaches and peer men-
tors who have already implemented changes in their
treatment agencies. Since the project’s inception in 2003,
participating providers have reported a 35 percent reduc-
tion in wait times, a 33 percent drop in the number of
no-shows, a 22 percent increase in admissions, and a 23
percent improvement in early retention rates. These
results have improved staff morale and the providers’
bottom lines. The NIATx Web site, www.NIATx.net,
offers a wealth of information on actual improve-
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complex formulas. Nothing is further from the truth.
To measure how your program is doing in key per-
formance areas like initiation and early retention, fol-
low the specifications on the WC’s Web site or the access
and retention measures on the NIATx Web site, and
start measuring how many clients come back for a visit
within 14 days and how many return twice more within
30 days of their first visit. Grab a baseline rate from a
quick review of when patients came into your pro-
gram and when they left. The data may be readily avail-
able, as your program is probably already reporting this
indicator to the state government. Discuss the baseline
results with your staff or clinical leadership over a brown
bag lunch. Together, determine how you can improve
the numbers by simple adaptations of current practices.
Consult the NIATx Web site for descriptions of how
community-based public sector providers have already
improved access and retention.
You may find that simply paying more attention to
your program’s initiation and early retention processes
improves your performance indicators and that there is
no need to make any formal changes. If so, pat your-
self and your staff on the back, because your willingness
to consider improvements may have increased your
patients’ chances of succeeding in that crucial first month
of treatment when so many drop out or give up. If the
change exercise doesn’t improve your organization’s per-
formance, don’t fret. Consult with staff involved in imple-
menting the change, and try something else. Make sure
you have a strong change leader and executive-level
endorsement for the change, so you can count on some
support when the implementation process gets a little
bumpy.
The French philosopher Voltaire wrote, “The best
is enemy of the good.” Don’t let apprehensions about
the quality of the data stop you from acting. Use what
you have to initiate a change process. The NIATx Web
site also provides guidance on how to do this.
For some programs—especially large, hospital-based
programs—the problem may be too much data. It’s not
unusual, for example, for the substance abuse and the
mental health clinics of the same hospital to be unable
to share data with each other or even for each clinic to
be unaware of what data the other has at its disposal.
The trick to avoid paralysis by such technical challenges
is to be practical and concrete. Get started with data you
can manage, perhaps with some informal help from the
management information systems department or a
friendly researcher in a local university or college.
Select an area for change that has some real traction
with staff, and identify an “idea champion” who is
respected by staff and interested in improving this par-
ticular aspect of care. Use what has already been col-
lected as much as possible, rather than burdening staff
with extra paperwork. Involve the staff who will do
the work when organizing the QPI project. If additional
reporting is necessary, make sure your idea champion
and your staff understand and accept the need for the
extra burden, with the stated purpose that the tempo-
rary increase in paperwork will lead to better patient out-
comes or reduced burdens down the line.
Use the Data You Collect
Nothing frustrates clinicians more than spending their
limited counseling time on paperwork that seems to dis-
appear into the black hole of the administration or a
funding agency. To secure staff support for performance
improvement efforts, make sure the change exercise is
relevant, the data get used, and the findings are reported
to the people collecting the data. Challenge your
funding agency to examine the necessity of the current
data collection requirements. Make the data as user-
friendly as possible, and make sure that it benefits the
clinical process in tangible ways.
Partner With a Researcher
A research partner can greatly facilitate your efforts to
develop a measurement-driven QPI culture. For example,
when scoring a proposed research study for funding, both
NIDA and the National Institute on Alcohol Abuse and
Alcoholism consider the project’s potential impact on
patient outcomes and look for evidence of earlier pilot
studies or other research for the timeliness and relevance
of the research question. Take advantage of the opportu-
nity these policies afford by partnering with a researcher
on a QPI project whose results and data may also serve
as a backdrop for a more formal research application.
Create a Crisis
Get a copy of SAMHSA’s National Outcome Measures,
and ask the staff person in charge of information
technology how the organization is going to capture
these data and how the data will look to consumers and
regulators when reported. Do the same with your board
of directors and other stakeholders—alumni, patient
advisory boards, and elected officials. Share the prob-
lem. Do not wait to be told that your program’s (and
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zation’s ability to collect, analyze, and use data to improve
performance. The literature consistently identifies lead-
ership as a key variable in the success of innovative,
adaptive organizations. Take this role seriously, and
gather the support you need to transform your organi-
zation’s culture.
State Agency Managers
Single State Agencies (SSAs) will not achieve desired
quality outcomes through regulation alone. Regulations
may bring compliance, but compliance scores are not
equivalent to quality outcomes. Nevertheless, SSAs have
powerful tools at their disposal to assume a leadership
role in QPI work.
Exercise Leadership
Improving quality and patient outcomes is the shared
responsibility of every manager and unit in the state
agency. SSA leaders should express this formally to employ-
ees. Reinforce this value through agency-wide briefings
on the principles of QPI and its importance to the SSA’s
overall mission. Many of the ongoing functions of a state
agency can support a QPI agenda, if the agency per-
sonnel are trained to identify opportunities for QPI activ-
ities within their ongoing responsibilities.
Form an Interdivisional Committee
The agency’s program, budget, auditing, and technical
assistance functions must recognize their individual and
collective roles in fostering and managing QPI activi-
ties. There often are unrecognized opportunities to pro-
mote a QPI agenda during contracting and review activ-
ities that do not affect funding levels, but communicate
a powerful message about the importance of QPI to the
State. For example, the Interdivisional Committee might
agree to a standardized approach to a common problem
confronting managers and providers, such as screen-
ing all new clients for mental health problems. In col-
laboration with the provider community, the Inter-
divisional Committee would design a Plan-Do-Study-
Act series to identify and implement a standard approach
to screening. Members of the committee would:
• Review ATTC and other SAMHSA resources in select-
ing a screening approach;  
• Ensure that all components of the agency had input
into the design of the Plan-Do-Study-Act series and
are prepared to support its implementation; and
• Collect data to evaluate the impact of the screen on
identification and early retention rates for persons with
co-occurring disorders, ensuring that the value, or lack
of value, in adopting this practice is known. 
Partner With Providers and Local Government
Performance improvement must be an SSA-endorsed,
provider-driven process. If the State is to be the guardian
of quality, the providers must be its managers. The patient-
centered system of care envisioned in the IOM report
is impossible without an active partnership among gov-
ernment, providers, and consumer representatives. The
State is best positioned to convene and manage the col-
laboration. A survey of providers and counties on
their use of EBPs and QPI processes can generate inter-
est as well as information on improving outcomes by
improving quality.
Contract for Performance
Pay for performance is a relatively new construct in
the substance abuse services field. Marton, Daigle,
and de la Gueronniere (2005) identified three types of
“purchasing levers” among states promoting the use of
EBPs in substance abuse treatment: standardization of
criteria, contractual requirements, and performance
incentives. Incentives include financial payments, reg-
ulatory relief, competitive bidding process advantage,
and infrastructure support. The State of Delaware has
incorporated payment incentives into its provider con-
tracts in three areas: engagement/utilization, attendance,
and program completion (Kemp, 2006). An evaluation
of the effects of the incentive payments on provider per-
formance is currently under way.
Performance-based contracting and reimbursement
practices for substance abuse services are in the early stages
of development. Pilot studies of incentives within exist-
ing State-provider contractual relationships for QPI activ-
ities and improved outcomes will open a window on a
key factor in sustaining QPI processes over the long term.
CONCLUSION
The substance abuse service system is in the early stages
of a major transition to a more accountable, consumer-
centered system of care, where the use of EBPs is the
norm and performance is measured and transparent.
The tools to effect this transition—the EBPs, perform-
ance measures, and implementation methods—are avail-
able now. Quality and performance improvement stan-
dards will take hold only if all parties in the delivery of
substance abuse services collaborate to align policies and
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RESPONSE: SETTING THE STAGE FOR IMPROVEMENT AND 
ACCOUNTABILITY
Linda Bradshaw, M.A.; Deborah Garnick, Sc.D.; and Daniel R. Kivlahan, Ph.D. 
Deborah Garnick: Dr. McCorry provides
a concise overview of several large, national
efforts in performance measurement and
quality improvement. He has done an excel-
lent job of bringing together the work of the
Washington Circle, Network for the
Improvement of Addiction Treatment
(NIATx), National Outcome Measures, and
Clinical Trials Network. The article is a fine
starting point for someone to get a sense of
the landscape and to jump off, using the
links and references he provides, to more
detail about each of the projects.
Daniel Kivlahan: I particularly like the image
of the three-legged stool, emphasizing how
interrelated these three major themes are—
the content, the data and measurement fea-
tures, and then the quality improvement
efforts. That’s the broad context that makes
a huge difference in how far a particular agency
is likely to get with implementation.
Each of the projects discussed in the
paper provides a different spectrum of options
for instituting quality and performance 
measurement and improvement. The NIATx
system starts at the front door of the organ-
ization, so it can give a lot of clues about
patient-level experiences and barriers to bet-
ter outcomes that programs might overlook.
The National Registry of Evidence-Based
Programs and Practices becomes useful when
clients have gotten through those early treat-
ment hoops and are waiting for at least some
initial intervention.
Linda Bradshaw: Of Dr. McCorry’s tips
on how to get started, I was impressed by
the create-a-crisis concept: challenging your
local boards and people in your agency to
take a hard look at the wave of the very near
future and start getting ready for it. That
seems a very practical way to go about get-
ting someone’s attention.
Kivlahan: Another approach might be to
ask the line staff what kind of information
was on the last list or spreadsheet they saw.
For example, staff members frequently get
lists of chart deficiencies, things they haven’t
documented appropriately. Reviewing these
together would reinforce the commitment
to measurement by reiterating the impor-
tance of the items on the list. The discussion
might produce a consensus that you are track-
ing the right things, or it might lead to a shift
to other, more productive measures.
Selecting practices
Garnick: The National Quality Forum
report, Evidence-Based Practices to Treat
Substance Use Conditions,is currently avail-
able on the Web for public comment. I
think people will be pleasantly surprised to
see that it talks about general practices and
approaches, not specific applications. For
example, it calls for more efforts at screen-